A Study of LY2140023 in Healthy Males and Females

NCT01591330 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY2140023 Reference form
DRUG: LY2140023 Test-Low
DRUG: LY2140023 Test-Medium
DRUG: LY2140023 Test-High

Sponsor

Denovo Biopharma LLC